CITRARO, Rita
 Distribuzione geografica
Continente #
NA - Nord America 4.762
AS - Asia 3.061
EU - Europa 1.876
SA - Sud America 601
Continente sconosciuto - Info sul continente non disponibili 285
AF - Africa 83
OC - Oceania 36
Totale 10.704
Nazione #
US - Stati Uniti d'America 4.513
SG - Singapore 1.280
IT - Italia 894
CN - Cina 678
BR - Brasile 462
VN - Vietnam 284
DE - Germania 272
IN - India 261
CA - Canada 187
BD - Bangladesh 167
GB - Regno Unito 165
FI - Finlandia 146
HK - Hong Kong 127
SE - Svezia 114
NL - Olanda 53
AR - Argentina 46
MX - Messico 39
ID - Indonesia 35
AU - Australia 34
FR - Francia 32
JP - Giappone 30
ES - Italia 28
IQ - Iraq 27
TR - Turchia 27
ZA - Sudafrica 26
RU - Federazione Russa 25
CO - Colombia 22
EC - Ecuador 22
UA - Ucraina 22
PK - Pakistan 18
UZ - Uzbekistan 18
PL - Polonia 17
CL - Cile 15
CZ - Repubblica Ceca 15
SA - Arabia Saudita 15
IL - Israele 14
RO - Romania 13
GR - Grecia 12
PH - Filippine 12
VE - Venezuela 12
IR - Iran 11
EG - Egitto 9
MA - Marocco 9
AT - Austria 8
CH - Svizzera 8
PY - Paraguay 8
KR - Corea 7
MT - Malta 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
HR - Croazia 6
KE - Kenya 6
TN - Tunisia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
DO - Repubblica Dominicana 5
EE - Estonia 5
JO - Giordania 5
KZ - Kazakistan 5
MY - Malesia 5
PT - Portogallo 5
SC - Seychelles 5
HN - Honduras 4
JM - Giamaica 4
LT - Lituania 4
NG - Nigeria 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
UY - Uruguay 4
AF - Afghanistan, Repubblica islamica di 3
AO - Angola 3
BO - Bolivia 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
GA - Gabon 3
IE - Irlanda 3
LK - Sri Lanka 3
NP - Nepal 3
SN - Senegal 3
AL - Albania 2
CR - Costa Rica 2
CY - Cipro 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
GD - Grenada 1
GH - Ghana 1
Totale 10.415
Città #
San Jose 730
Singapore 512
Chandler 430
Ashburn 382
Dallas 364
Munich 230
Santa Clara 223
Milan 170
Bengaluru 169
Hefei 166
Beijing 155
Council Bluffs 153
Princeton 129
Catanzaro 128
Lawrence 128
Hong Kong 120
Ottawa 100
Ho Chi Minh City 99
London 94
Chicago 93
Wilmington 76
New York 73
Turku 69
Helsinki 68
Los Angeles 66
Hanoi 52
Boardman 48
Des Moines 44
Catania 43
São Paulo 42
Orem 36
Rome 36
Redwood City 31
Brooklyn 29
Montreal 29
Amsterdam 24
Tokyo 24
Palermo 23
San Francisco 22
Shanghai 22
Haiphong 21
Atlanta 18
Chennai 18
Toronto 18
Florence 17
Rio de Janeiro 17
Guangzhou 16
Johannesburg 16
Tashkent 16
Boston 15
Da Nang 15
Mexico City 15
Naples 15
The Dalles 15
Buffalo 14
Melbourne 14
Norwalk 14
Phoenix 13
San Nicola Manfredi 13
Shenzhen 12
Stockholm 12
Warsaw 12
Aversa 11
Brasília 11
Denver 11
Olomouc 11
Bari 10
Istanbul 10
Messina 10
Sydney 10
Dhaka 9
Prato 9
Riyadh 9
Hải Dương 8
Madrid 8
Padova 8
Pune 8
Salvador 8
Vancouver 8
Washington 8
West Jordan 8
Ankara 7
Baghdad 7
Belo Horizonte 7
Biên Hòa 7
Bogotá 7
Bologna 7
Boydton 7
Bắc Giang 7
Campinas 7
Can Tho 7
Charlotte 7
Columbus 7
Curinga 7
Curitiba 7
Guayaquil 7
Houston 7
Jakarta 7
Newark 7
Nuremberg 7
Totale 6.076
Nome #
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 366
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 256
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 151
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 144
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 137
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 133
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 129
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 125
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 118
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 111
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 108
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 108
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 99
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 92
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 91
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 90
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 90
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 88
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 87
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 86
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 86
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 85
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 84
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 83
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 81
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 81
Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy 80
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 79
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 79
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 79
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 76
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 75
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 75
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 75
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 74
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 74
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 74
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 73
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 73
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 72
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 71
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 71
The potential role of cannabinoids in epilepsy treatment. 70
Vasostatin-1 restores autistic disorders in an idiopathic autism model (BTBR T+ Itpr3tf/J mice) by decreasing hippocampal neuroinflammation 69
Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study 69
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 69
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 69
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence 68
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 68
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  68
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 68
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 68
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 68
Oleil hydroxytyrosol (Htol) exerts anti-myeloma activity by antagonizing key survival pathways in malignant plasma cells (CO-FIRST AUTHOR) 67
A questionnaire-based study on prevalence and treatments of headache in Secondary Schools people of Catanzaro 66
Pharmacokinetic considerations about antiseizure medications in the elderly 66
Epidemiology and outcomes of status epilepticus 66
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 64
Bioinspired Electric Stimulation: Comparison of ECoG Spectrum in the Main Auditory Structures 64
Long-Term High-Fat Diet Aggravates Absence Seizures and Neurobehavioral Disorders Without Inducing Metabolic Disorders in WAG/Rij Rats: Involvement of Systemic and Central Inflammation 63
Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice 63
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 62
Microbiota-gut brain axis involvement in neuropsychiatric disorders 62
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures. Expert Opin Pharmacother. 2014 Jan 17. [Epub ahead of print] PubMed PMID: 24437529. 62
Intestinal inflammation increases convulsant activity and reduces antiepileptic drug efficacy in a mouse model of epilepsy 62
Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats 61
Antidepressants drugs for seizures and epilepsy: Where do we stand? 60
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 60
Development of 3-substituted-1H-indole derivatives as NR2B/NMDA receptor antagonists 60
Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior 59
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 59
Statins and Epilepsy: Preclinical Studies, Clinical Trials and Statin-Anticonvulsant Drug Interactions 59
Nano‐hydrogel embedded with quercetin and oleic acid as a new formulation in the treatment of diabetic foot ulcer: A pilot study 59
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 58
Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis 58
Colchicine in Managing Skin Conditions: A Systematic Review 58
A Multiple Synergic Treatment for Non-Healing Ulcer Management in a Patient with Klippel–Trenaunay Syndrome 57
Immediate and controlled-release pregabalin for the treatment of epilepsy 57
Butyrate prevents valproate-induced liver injury: In vitro and in vivo evidence 57
An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy 57
Glucagon induces the hepatic expression of inflammatory markers in vitro and in vivo 57
An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists 56
Effect of Statins on Lung Cancer Molecular Pathways: A Possible Therapeutic Role 56
HDL (High-Density Lipoprotein) and ApoA-1 Potentially Modulate Pancreatic α-Cell Glucagon Secretion 56
Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis 56
Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study 55
Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region 55
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity 55
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy 55
Direct Modulation of High-Frequency Neural Oscillations in the Auditory Cortex Through Electrical Microstimulation Generated by PVDF Sensors 55
Seizure susceptibility to various convulsant stimuli in the BTBR mouse model of autism spectrum disorders 54
Prescribing Pattern and Safety Profile of Biological Agents for Psoriasis in Real-World Practice: A Four-Year Calabrian Pharmacovigilance Analysis 54
Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs 54
Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy? 54
Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats 54
Synthesis and anticonvulsant evaluation of N-substituted isoquinoline AMPA receptor antagonists 54
Pharmacovigilance in pharmaceutical companies: An overview 53
Metalloproteases in Pain Generation and Persistence: A Possible Target? 52
Oxygen–Ozone Therapy in Cervicobrachial Pain: A Real-Life Experience 52
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 52
Totale 7.798
Categoria #
all - tutte 87.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.696


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022432 0 6 9 92 21 14 7 84 79 50 58 12
2022/20231.248 263 101 48 109 120 102 15 81 191 86 91 41
2023/2024734 120 90 63 61 54 121 31 46 11 47 29 61
2024/20252.141 262 71 105 90 143 262 161 94 237 71 266 379
2025/20265.210 303 448 556 674 512 244 653 256 636 422 308 198
2026/2027361 105 256 0 0 0 0 0 0 0 0 0 0
Totale 10.704